Risk factors for sub–therapeutic serum concentrations of magnesium sulfate in severe preeclampsia of Chinese patients

[1]  L. Katz,et al.  Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia , 2019, Medicine.

[2]  P. Lumbiganon,et al.  Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure‐Response Modeling and Simulation Study , 2019, Journal of clinical pharmacology.

[3]  P. Lumbiganon,et al.  Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia , 2018, Journal of clinical pharmacology.

[4]  ACOG Practice Bulletin No. 202 Summary: Gestational Hypertension and Preeclampsia. , 2019, Obstetrics and gynecology.

[5]  T. Wataganara,et al.  A retrospective review of on-admission factors on attainment of therapeutic serum concentrations of magnesium sulfate in women treated for a diagnosis of preeclampsia , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[6]  B. Winikoff,et al.  A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion , 2018, BMC Pregnancy and Childbirth.

[7]  W. H. Pearse,et al.  American College of Obstetricians and Gynecologists , 2018, Definitions.

[8]  J. Repke,et al.  Pitfalls With the New American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy , 2017, Clinical obstetrics and gynecology.

[9]  D. Lyell,et al.  Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. , 2016, American journal of obstetrics and gynecology.

[10]  A. Gülmezoglu,et al.  Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia , 2015, BJOG : an international journal of obstetrics and gynaecology.

[11]  D. Hawks.  The American College of Obstetricians and Gynecologists (ACOG) , 2014 .

[12]  James M. Roberts,et al.  Hypertension in Pregnancy: Executive Summary , 2013 .

[13]  P. Vicini,et al.  Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study , 2013, BJOG : an international journal of obstetrics and gynaecology.

[14]  S. Manotaya,et al.  Magnesium sulfate maintenance infusion in women with preeclampsia: a randomized comparison between 2 gram per hour and 1 gram per hour. , 2013, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[15]  A. Odutayo,et al.  Obstetric nephrology: renal hemodynamic and metabolic physiology in normal pregnancy. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[16]  G. Dekker,et al.  Guidelines for the management of hypertensive disorders of pregnancy 2008 , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

[17]  M. Druzin,et al.  Course of preeclamptic glomerular injury after delivery. , 2008, American journal of physiology. Renal physiology.

[18]  L. Doyle,et al.  The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years , 2006, BJOG : an international journal of obstetrics and gynaecology.

[19]  D. Haas.  Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. , 2007, Obstetrics and gynecology.

[20]  K. Leveno,et al.  Selective Magnesium Sulfate Prophylaxis for the Prevention of Eclampsia in Women With Gestational Hypertension , 2006, Obstetrics and gynecology.

[21]  B. Sibai.  Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. , 2004, American journal of obstetrics and gynecology.

[22]  Z. Sahinoglu,et al.  The Use of Standard Dose of Magnesium Sulphate in Prophylaxis of Eclamptic Seizures: Do Body Mass Index Alterations Have Any Effect on Success? , 2003, Hypertension in pregnancy.

[23]  M. Ross,et al.  Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia. , 2002, American journal of obstetrics and gynecology.

[24]  B. Charles,et al.  Population pharmacokinetics of magnesium in preeclampsia. , 2001, American journal of obstetrics and gynecology.

[25]  C. Nightingale,et al.  Magnesium Sulfate in Eclampsia and Pre-Eclampsia , 2000, Clinical pharmacokinetics.

[26]  J. Repke,et al.  Preeclampsia Prevention and Management , 2000, The Journal of the Society for Gynecologic Investigation: JSGI.

[27]  J. Repke,et al.  Preeclampsia prevention and management. , 2000 .

[28]  B. Sibai,et al.  MAGNESIUM SULFATE THERAPY IN PREECLAMPSIA AND ECLAMPSIA , 1998, Obstetrics and gynecology.

[29]  C. Roy,et al.  Fast imaging MR assessment of ureterohydronephrosis during pregnancy. , 1995, Magnetic resonance imaging.

[30]  W. Phuapradit,et al.  Serum level of magnesium attained in magnesium sulfate therapy for severe preeclampsia. , 2010, Asia-Oceania journal of obstetrics and gynaecology.

[31]  J. Graham,et al.  A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. , 1984, American journal of obstetrics and gynecology.

[32]  B. Sibal,et al.  Reassessment of Intravenous MgSO4 Therapy in Preeclampsia–Eclampsia , 1981, Obstetrics and gynecology.

[33]  J. Henzen.  Publisher's note , 1979, Brain Research.

[34]  L. Chesley,et al.  Plasma levels of magnesium attained in magnesium sulfate therapy for preeclampsia and eclampsia. , 1957, The Surgical clinics of North America.

[35]  J. Pritchard.  The use of the magnesium ion in the management of eclamptogenic toxemias. , 1955, Surgery, gynecology & obstetrics.

[36]  N. J. Eastman,et al.  The Management of Pre-Eclampsia. , 1945, Canadian Medical Association journal.